clement, Author at BaseLaunch

Features

Novo Holdings invests in Polyphor

Danish company Novo Holdings is investing 6.8 million Swiss francs in the biopharmaceutical Polyphor from the canton of Basel-Landschaft. As a result, it hopes to…

clement06.09.2018

Features

Early-Stage Biotech Value Creation: The Roles of Equity and Partnerships

clement21.08.2018

Features

Basel leads the way with electronic health records

Switzerland’s first electronic health record has been opened in Basel. The University Hospital Basel will soon be offering the service to patients at its clinics.

clement16.08.2018

Features

Basel researchers develop new approach to terpene syntheses

Terpenes are a class of chemical compounds found in nature that also include clinical substances. Lab synthesis has always been very difficult, but Basel scientists…

clement09.08.2018

Features

A factory no bigger than a molecule, now producing fuels, chemicals and materials

An article by Jim Lane, published by BiofulesDigest A team from the University of Basel, Switzerland has come up with a black box the size…

clement08.08.2018

Features

Home run exits happen stealthily for biotech

An article by Joanna Glasner, Contributor at Techcrunch Startup exit tallies commonly underestimate biotech returns. Unlike most tech deals, the biggest profits in bio often…

clement02.08.2018

Features

Consumer Health drives growth at Lonza

Lonza, a pharmaceutical company from Basel, has published pleasing half-year results, with positive momentum driven by its new Consumer Health division. Lonza has reported 8.2 per…

clement02.08.2018

Interviews

Selection committe member Julian Bertschinger

The competition for financing is intense. How and which projects do you choose to back? Julian Bertschinger: At Johnson & Johnson we collaborate with and…

clement10.07.2018

Roivant will not shy away from taking risks

Interviews

“We will not shy away from taking risks”

In 2016, Roivant Sciences established their global headquarters in Basel. Roivant founder and CEO Vivek Ramaswamy talked to us about his fast growing company, his priorities…

clement04.07.2018

Features

Two of the world’s most valuable companies come from Basel

With Roche and Novartis, two Basel pharma companies are among the 40 most valuable companies in the world.

clement04.07.2018

clement

Novo Holdings invests in Polyphor

Early-Stage Biotech Value Creation: The Roles of Equity and Partnerships

Basel leads the way with electronic health records

Basel researchers develop new approach to terpene syntheses

A factory no bigger than a molecule, now producing fuels, chemicals and materials

Home run exits happen stealthily for biotech

Consumer Health drives growth at Lonza

Selection committe member Julian Bertschinger

“We will not shy away from taking risks”

Two of the world’s most valuable companies come from Basel

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us